Cancers Review is an international, peer-reviewed journal dedicated to advancing knowledge in all areas of cancer research, prevention, diagnosis, treatment, and survivorship. The journal serves as a comprehensive platform for clinicians, researchers, and healthcare professionals working across oncology, molecular biology, pathology, pharmacology, immunology, epidemiology, medicinal sciences, and related disciplines.
Cancer remains one of the most complex and devastating diseases affecting humanity. The ultimate goal of cancer research is to understand the biological mechanisms underlying cancer development and progression, improve diagnostic and therapeutic strategies, and ultimately reduce the global burden of cancer through effective prevention and cure. Achieving these objectives requires strong collaboration between basic scientists, translational researchers, and clinical investigators.
Cancers Review aims to bridge the gap between fundamental cancer biology and clinical application by publishing high-quality review articles, original research papers, short communications, and perspectives that contribute to the understanding and management of cancer. The journal welcomes studies ranging from molecular and cellular mechanisms of carcinogenesis to translational and clinical oncology, including innovative therapeutic approaches and patient-centered care.
Subject Areas
The journal covers, but is not limited to, the following areas:
-
Cancer Biology and Molecular Oncology
-
Tumor Genetics and Genomics
-
Cancer Biomarkers and Diagnostics
-
Precision Medicine and Personalized Oncology
-
Cancer Immunology and Immunotherapy
-
Cancer Prevention and Screening
-
Cancer Epidemiology and Public Health
-
Cancer Pharmacology and Drug Development
-
Chemotherapy, Radiotherapy, Radiosurgery, and Brachytherapy
-
Surgical Oncology
-
Palliative Care and Cancer Survivorship
-
Alternative and Complementary Therapies for Cancer
-
Translational and Clinical Cancer Research
-
Pediatric Oncology
-
Cancer Pathology and Carcinogenesis
Specific Cancer Types
Research related to all benign and malignant neoplasms is considered, including:
-
Breast Cancer (including Male Breast Cancer)
-
Lung Cancer (Small Cell and Non-Small Cell)
-
Colorectal, Colon, and Rectal Cancer
-
Prostate Cancer
-
Ovarian, Cervical, Endometrial, Uterine, Vaginal, and Vulvar Cancers
-
Liver Cancer and Hepatocellular Carcinoma
-
Pancreatic Cancer
-
Gastric and Esophageal Cancer
-
Bladder, Kidney, Renal, Ureteral, and Urethral Cancers
-
Brain Tumors, Glioma, Meningioma, and Neuroblastoma
-
Leukemia (Adult and Childhood)
-
Lymphoma and Hodgkin’s Disease
-
Multiple Myeloma, Plasmacytoma, and Plasma-Cell Myeloma
-
Melanoma and Other Skin Cancers
-
Head and Neck, Oral, Nasal, Pharyngeal, and Laryngeal Cancers
-
Thyroid, Thymus, and Testicular Cancers
-
Bone Cancer, Osteosarcoma, Ewing’s Sarcoma, and Soft Tissue Sarcoma
-
Retinoblastoma and Other Ocular Malignancies
-
Mesothelioma, Kaposi’s Sarcoma, Wilms’ Tumor, and other rare cancers
The journal encourages interdisciplinary research that enhances understanding of cancer pathogenesis, improves patient outcomes, and supports the global effort toward cancer prevention, control, and cure.